Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Warren J. Rocque is active.

Publication


Featured researches published by Warren J. Rocque.


Cell | 1996

Crystal Structure and Mutational Analysis of the Human CDK2 Kinase Complex with Cell Cycle–Regulatory Protein CksHs1

Yves Bourne; Mark H. Watson; Michael J. Hickey; William Holmes; Warren J. Rocque; Steven I. Reed; John A. Tainer

The 2.6 Angstrom crystal structure for human cyclin-dependent kinase 2(CDK2) in complex with CksHs1, a human homolog of essential yeast cell cycle-regulatory proteins suc1 and Cks1, reveals that CksHs1 binds via all four beta strands to the kinase C-terminal lobe. This interface is biologically critical, based upon mutational analysis, but far from the CDK2 N-terminal lobe, cyclin, and regulatory phosphorylation sites. CDK2 binds the Cks single domain conformation and interacts with conserved hydrophobic residues plus His-60 and Glu-63 in their closed beta-hinge motif conformation. The beta hinge opening to form the Cks beta-interchanged dimer sterically precludes CDK2 binding, providing a possible mechanism regulating CDK2-Cks interactions. One face of the complex exposes the sequence-conserved phosphate-binding region on Cks and the ATP-binding site on CDK2, suggesting that CKs may target CDK2 to other phosphoproteins during the cell cycle.


Acta Crystallographica Section D-biological Crystallography | 2007

Crystallization of protein-ligand complexes.

Anne M. Hassell; Gang An; Randy K. Bledsoe; Jane M. Bynum; H. Luke Carter; Su-Jun J. Deng; Robert T. Gampe; Tamara E. Grisard; Kevin P. Madauss; Robert T. Nolte; Warren J. Rocque; Liping Wang; Kurt Weaver; Shawn P. Williams; G. Bruce Wisely; Robert X. Xu; Lisa M. Shewchuk

Methods presented for growing protein–ligand complexes fall into the categories of co-expression of the protein with the ligands of interest, use of the ligands during protein purification, cocrystallization and soaking the ligands into existing crystals.


Bioorganic & Medicinal Chemistry Letters | 1998

The formation of a covalent complex between a dipeptide ligand and the src SH2 domain.

Krystal J. Alligood; Paul S. Charifson; Renae M. Crosby; Thomas G. Consler; Paul L. Feldman; Robert T. Gampe; Tona M. Gilmer; Steven R. Jordan; Mark W. Milstead; Christopher Mohr; Michael Robert Peel; Warren J. Rocque; Marc Rodriguez; David W. Rusnak; Lisa M. Shewchuk; Daniel D. Sternbach

The X-ray crystal structure of the src SH2 domain revealed the presence of a thiol residue (Cys 188) located proximal to the phosphotyrosine portion of a dipeptide ligand. An aldehyde bearing ligand (1) was designed to position an electrophilic carbonyl group in the vicinity of the thiol. X-ray crystallographic and NMR examination of the complex formed between (1) and the src SH2 domain revealed a hemithioacetal formed by addition of the thiol to the aldehyde group with an additional stabilizing hydrogen bond between the acetal hydroxyl and a backbone carbonyl.


Journal of Medicinal Chemistry | 2000

Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase.

Lisa M. Shewchuk; Anne M. Hassell; Bruce Wisely; Warren J. Rocque; William Holmes; James Marvin Veal; Lee F. Kuyper


Science | 2001

Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors

Stephen T. Davis; Bill G. Benson; H. Neal Bramson; Dennis E. Chapman; Scott Howard Dickerson; Karen M. Dold; Derek J. Eberwein; Mark P. Edelstein; Stephen V. Frye; Robert T. Gampe; Robert J. Griffin; Philip A. Harris; Anne M. Hassell; William Holmes; Robert Neil Hunter; Victoria B. Knick; Karen Elizabeth Lackey; Brett Lovejoy; Michael Joseph Luzzio; Doris M. Murray; Patricia G. Parker; Warren J. Rocque; Lisa M. Shewchuk; James Marvin Veal; Duncan Herrick Walker; Lee F. Kuyper


Journal of Molecular Biology | 2004

Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.

Robert X. Xu; Warren J. Rocque; Millard H. Lambert; Dana E. Vanderwall; Michael A. Luther; Robert T. Nolte


Biochemistry | 1997

Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.

Paul S. Charifson; Lisa M. Shewchuk; Warren J. Rocque; Conrad W. Hummel; Steven R. Jordan; Christopher Mohr; Gregory J. Pacofsky; Michael Robert Peel; Marc Rodriguez; Daniel D. Sternbach; Thomas G. Consler


Biochemistry | 1997

Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities.

Warren J. Rocque; Tian G; Wiseman Js; William Holmes; Zajac-Thompson I; Willard Dh; Patel Ir; Wisely Gb; Clay Wc; Kadwell Sh; Hoffman Cr; Michael A. Luther


Biochemical Journal | 1996

Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase

James M. Lenhard; Daniel B. Kassel; Warren J. Rocque; Lawrence L. Hamacher; William Holmes; Indravadan R. Patel; Christine Hoffman; Michael A. Luther


Protein Expression and Purification | 1997

Detailed Characterization of a Purified Type 4 Phosphodiesterase, HSPDE4B2B: Differentiation of High- and Low-Affinity (R)-Rolipram Binding☆

Warren J. Rocque; William Holmes; Indravadan R. Patel; Robert W. Dougherty; Olivia Ittoop; Laurie K. Overton; Christine Hoffman; G. Bruce Wisely; Derril H. Willard; Michael A. Luther

Collaboration


Dive into the Warren J. Rocque's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge